Understanding medicinal cannabis laws, licensing requirements, patient access and the differences between Australian jurisdictions.
Australia's cannabis laws have changed considerably over the past decade, particularly following reforms that established a national framework for medicinal cannabis cultivation and production in 2016.
Today, cannabis is regulated through a combination of Commonwealth legislation and state and territory laws.
The rules differ depending on whether cannabis is being cultivated, manufactured, imported, prescribed, dispensed, possessed or used.
Understanding these distinctions is essential for patients, healthcare professionals, businesses and anyone interested in the Australian cannabis industry.
The legal position depends on the purpose of the activity and the jurisdiction involved.
Medicinal cannabis
Medicinal cannabis can be lawfully prescribed and supplied throughout Australia when the applicable legal and regulatory requirements are satisfied.
Non-medical cannabis
Non-medical cannabis possession, cultivation, supply and use remain restricted under Australian law. The precise offences, penalties and diversion arrangements vary between states and territories.
Industrial hemp
Industrial hemp is subject to separate licensing arrangements, generally involving approved low-THC cannabis varieties cultivated for authorised industrial or agricultural purposes.
These categories should not be confused, as different legal frameworks apply.
Several Commonwealth laws are central to the regulation of medicinal cannabis.
The Narcotic Drugs Act 1967 establishes controls relating to narcotic substances, including medicinal cannabis cultivation, production and relevant manufacturing activities.
Amendments introduced in 2016 established a national framework for licensed domestic medicinal cannabis cultivation and production.
The Therapeutic Goods Act 1989 governs the regulation of therapeutic goods in Australia.
It provides the legislative foundation for matters including medicine registration, manufacturing standards, access to unapproved therapeutic goods and advertising controls.
Commonwealth customs legislation regulates the import and export of cannabis and other controlled substances.
Businesses involved in international trade may require specific licences, permits and other authorisations.
The Office of Drug Control administers Commonwealth controls for activities including medicinal cannabis cultivation, production, relevant manufacturing, importation and exportation.
Businesses undertaking regulated activities must obtain the licences and permits applicable to those activities.
The Therapeutic Goods Administration regulates therapeutic goods, including medicinal cannabis products.
Its responsibilities include oversight of medicine quality requirements, therapeutic goods registration, access pathways for unapproved products and prescription medicine advertising rules.
State and territory governments regulate additional aspects of medicinal cannabis, including controlled-drug possession, prescribing, dispensing, storage and distribution.
The precise obligations depend on the jurisdiction and activity involved.
Medicinal cannabis is accessed through Australia's healthcare and medicines framework.
Some cannabinoid-based medicines are registered on the Australian Register of Therapeutic Goods (ARTG).
Many other medicinal cannabis products are unapproved therapeutic goods. These products have not undergone the TGA's full assessment for registration and are accessed through specific regulatory pathways.
The Special Access Scheme provides pathways through which eligible healthcare practitioners may arrange access to unapproved therapeutic goods for individual patients.
Requirements depend on the relevant scheme category, medicine and clinical circumstances.
The Authorised Prescriber Scheme allows eligible medical practitioners to prescribe specified unapproved therapeutic goods to particular patient groups under applicable authorisations and conditions.
Access to prescription medicinal cannabis requires an appropriate clinical assessment and lawful prescription.
The medicine must then be supplied and dispensed in accordance with applicable regulatory requirements.
There is no general requirement for patients to register personally with the TGA before receiving medicinal cannabis. Relevant regulatory applications and notifications are generally managed by healthcare practitioners.
Australian legislation does not establish a single universal list of medical conditions that automatically qualifies a patient for medicinal cannabis.
Clinical suitability depends on individual circumstances, the available evidence, the product involved and the applicable prescribing and regulatory requirements.
A prescription is not automatic, and medicinal cannabis is not appropriate for every patient.
Healthcare practitioners must exercise professional judgment and comply with relevant legal and clinical obligations.
Businesses participating in the medicinal cannabis industry may require different licences and permits depending on their activities.
Commercial cultivation and production of medicinal cannabis require appropriate Commonwealth licences and permits.
Applicants must satisfy requirements relating to suitability, security, facilities, recordkeeping and regulatory compliance.
Medicinal cannabis manufacturing is subject to applicable Commonwealth authorisations and therapeutic goods manufacturing requirements.
Different obligations may apply depending on the manufacturing activities undertaken.
Importing or exporting controlled cannabis substances generally requires relevant Commonwealth licences, permits or other permissions.
Wholesale supply is subject to applicable medicines and poisons legislation, including state and territory licensing requirements.
Businesses operating across multiple jurisdictions may need to satisfy several regulatory frameworks.
Holding one type of cannabis-related licence does not automatically authorise every other activity in the supply chain.
Australia does not have a general nationwide legal recreational cannabis market.
However, approaches to personal cannabis possession and use differ between jurisdictions.
The Australian Capital Territory has specific laws that exempt adults from certain criminal offences involving limited personal possession and home cultivation.
These arrangements are subject to restrictions and do not authorise commercial recreational cannabis sales.
Commonwealth laws may also remain relevant.
Elsewhere in Australia, criminal offences, penalties and diversion arrangements vary according to state and territory legislation.
Readers should consult current official government information rather than assume the same rules apply throughout Australia.
Driving laws are an important consideration for people prescribed medicinal cannabis.
THC can impair driving-related abilities, including attention, reaction time and coordination.
Australian jurisdictions have laws addressing drug-impaired driving and the presence of specified drugs.
In many jurisdictions, a lawful medicinal cannabis prescription does not provide a defence to a roadside THC detection offence.
Drivers should check the current laws in their jurisdiction and discuss relevant safety concerns with their healthcare professional.
Medicinal cannabis businesses operate within a framework intended to regulate product quality, traceability, controlled-drug handling and lawful supply.
Depending on the activity, relevant obligations may include:
Licensing and permit conditions
Manufacturing and quality standards
Product testing and documentation
Secure storage and distribution
Recordkeeping and reporting
Prescribing and dispensing requirements
Advertising restrictions
Regulatory inspections and audits
Compliance is an ongoing responsibility rather than a one-time licensing requirement.
The legal landscape of cannabis in Australia involves overlapping Commonwealth, state and territory frameworks.
Medicinal cannabis can be lawfully prescribed and supplied under established regulatory pathways, while cultivation, manufacturing, importation, wholesale distribution and dispensing are subject to distinct requirements.
Non-medical cannabis activities remain restricted, with important differences between jurisdictions.
Because legislation and regulatory guidance can change, individuals and businesses should rely on current official information and obtain professional advice where necessary.
Legal and educational disclaimer
This article is provided for general educational purposes only and does not constitute legal or medical advice. Laws and regulatory requirements may change. Readers should consult official government sources or suitably qualified professionals regarding their circumstances.